Study about the immunological investigations done before Kidney transplant in Basrah during (2012-2017)

Nibras S. Al-Ammar
{"title":"Study about the immunological investigations done before Kidney transplant in Basrah during (2012-2017)","authors":"Nibras S. Al-Ammar","doi":"10.33762/bsurg.2022.136517.1031","DOIUrl":null,"url":null,"abstract":"Kidney transplant considered as alternative treatment in end-stage renal disease. Human leukocyte antigens an important role in graft rejection, donor specific HLA antibodies that measured by panel reactive antibody, lead to increased sensitization. Cytomegalovirus, Epstein-Barr virus, Hepatitis-B, and -C viruses have an association with poor outcome of the transplant. The study is aimed to discuss the immunological investigations that were done before the transplant. The study has carried out in College of Medicine by analyzing the data records for 36 patients undergo kidney transplant in Al-Sadder Teaching Hospital, 5 patients were excluded because of incomplete data. Data has been recorded during (2012-2017). HLA (Human Leukocyte Antigens) matching between recipients and donors includ ing HLA-A, -B, -DR and -DRB1. Presence of PRAs (Panel Reactive Antibodies), Hepatitis B virus surface antigen (HBV sAg), Hepatitis C virus antibody (HCV Ab), Cytomegalovirus (CMV) IgM and IgG, Epstein-Barr virus (EBV) IgM and IgG screened in recipients. Out of 31 recipients, 83.9% were males and 16.1% were females. 77.4% of donors and recipients were relatives and 22.6% were not relatives. 22.6% of donors and 25.8% of recipients were tested for HLA and only 57.14% showed partially matching within some HLA classes. 9.7% of recipients have PRA. No recipient showed positive results for the presence of HBV sAg and HCV Ab. 6.5% of recipients have CMV IgM, 67.7% have CMV IgG, 9.7% showed positive results for the presence of EBV IgM and 6.5% have EBV IgG. Inconclusion, recipients and donors showed partially matched HLA classes, not all recipients and donors tested for HLA matching. Some recipients have PRA, high percentage of recipients has CMV IgG, and some of them have CMV IgM antibodies. All these factors might effects on the fate of transplant. HLA-DQ have to be tested and screening for the presence of PRA, viral Ag or Abs specific to these viruses in both recipients and donors is recom -mended.","PeriodicalId":52765,"journal":{"name":"Basrah Journal of Surgery","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basrah Journal of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33762/bsurg.2022.136517.1031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Kidney transplant considered as alternative treatment in end-stage renal disease. Human leukocyte antigens an important role in graft rejection, donor specific HLA antibodies that measured by panel reactive antibody, lead to increased sensitization. Cytomegalovirus, Epstein-Barr virus, Hepatitis-B, and -C viruses have an association with poor outcome of the transplant. The study is aimed to discuss the immunological investigations that were done before the transplant. The study has carried out in College of Medicine by analyzing the data records for 36 patients undergo kidney transplant in Al-Sadder Teaching Hospital, 5 patients were excluded because of incomplete data. Data has been recorded during (2012-2017). HLA (Human Leukocyte Antigens) matching between recipients and donors includ ing HLA-A, -B, -DR and -DRB1. Presence of PRAs (Panel Reactive Antibodies), Hepatitis B virus surface antigen (HBV sAg), Hepatitis C virus antibody (HCV Ab), Cytomegalovirus (CMV) IgM and IgG, Epstein-Barr virus (EBV) IgM and IgG screened in recipients. Out of 31 recipients, 83.9% were males and 16.1% were females. 77.4% of donors and recipients were relatives and 22.6% were not relatives. 22.6% of donors and 25.8% of recipients were tested for HLA and only 57.14% showed partially matching within some HLA classes. 9.7% of recipients have PRA. No recipient showed positive results for the presence of HBV sAg and HCV Ab. 6.5% of recipients have CMV IgM, 67.7% have CMV IgG, 9.7% showed positive results for the presence of EBV IgM and 6.5% have EBV IgG. Inconclusion, recipients and donors showed partially matched HLA classes, not all recipients and donors tested for HLA matching. Some recipients have PRA, high percentage of recipients has CMV IgG, and some of them have CMV IgM antibodies. All these factors might effects on the fate of transplant. HLA-DQ have to be tested and screening for the presence of PRA, viral Ag or Abs specific to these viruses in both recipients and donors is recom -mended.
巴士拉肾移植前免疫学调查研究(2012-2017)
肾移植被认为是终末期肾病的替代治疗方法。人类白细胞抗原在移植物排斥反应中起着重要作用,供体特异性HLA抗体通过面板反应性抗体测定,导致增敏。巨细胞病毒、EB病毒、乙型肝炎和丙型肝炎病毒与移植效果不佳有关。这项研究旨在讨论移植前进行的免疫学研究。这项研究是在医学院进行的,通过分析Al Sadder教学医院36名肾移植患者的数据记录,其中5名患者因数据不完整而被排除在外。数据记录在(2012-2017年)期间。受体和供体之间的HLA(人类白细胞抗原)匹配包括HLA-A、-B、-DR和-DRB1。在受试者中筛选出PRAs(群体反应性抗体)、乙型肝炎病毒表面抗原(HBV sAg)、丙型肝炎病毒抗体(HCV Ab)、巨细胞病毒(CMV)IgM和IgG、EB病毒(EBV)IgM和IgG。在31名接受者中,83.9%为男性,16.1%为女性。77.4%的捐赠者和接受者是亲属,22.6%不是亲属。22.6%的供体和25.8%的受体进行了HLA检测,只有57.14%的供体和受体在某些HLA类别中显示出部分匹配。9.7%的受试者患有PRA。没有受试者显示HBV sAg和HCV Ab阳性结果。6.5%的受试者具有CMV IgM,67.7%具有CMV IgG,9.7%具有EBV IgM阳性结果,6.5%具有EBV IgG。结论:受者和供者显示出部分匹配的HLA类别,并非所有受者和受者都进行了HLA匹配测试。一些受试者患有PRA,高比例的受试者具有CMV IgG,其中一些人具有CMV IgM抗体。所有这些因素都可能影响移植的命运。必须检测HLA-DQ,并建议在受体和供体中筛查PRA、病毒Ag或Abs的存在。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
8
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信